首页> Cancer medicine> Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.

Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.

导出 LinkOut

翻译打印收藏纠错

第一作者： Adam,Khan

第一单位： Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA.

作者： Adam,Khan ^[1] ; Hassan,Khan ^[1] ; Griffin K,Hughes ^[1] ; Chase,Ladd ^[1] ; Ryan,McIntire ^[1] ; Brooke,Gardner ^[1] ; Andriana M,Peña ^[1] ; Abigail,Schoutko ^[2] ; Jordan,Tuia ^[3] ; Kirstien,Minley ^[1] ; Alyson,Haslam ^[3] ; Vinay,Prasad ^[3] ; Matt,Vassar ^[4]

作者单位： Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA. ^[1] Department of Internal Medicine, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA. ^[2] Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA. ^[3] Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA.;Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA. ^[4]

医学主题词人类(Humans);危险性评估(Risk Assessment);临床试验(主题)(Clinical Trials as Topic);肿瘤(Neoplasms);抗肿瘤药(Antineoplastic Agents)

DOI 10.1002/cam4.7130

PMID 38698690

发布时间 2024-06-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer medicine

2024年13卷9期

e7130页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cancer medicine

2024年13卷9期

e7130页

检索历史清除

Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.

Cancer medicine

相似文献

同项目论文

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.

Cancer medicine

相似文献

同项目论文

Cancer medicine

相关期刊

检索历史清除